Wednesday, 18 September 2019

Biologics News

  • ParkwayHealth offers HBsAg Quantitative Assay

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    Singapore: ParkwayHealth Laboratory, a clinical laboratory service provider in Singapore, is to provide Hepatitis B Surface Antigen (HBsAg) quantitative assay.With HBsAg Quantitative Assay,...Read more

  • Rheumatoid arthritis mAb market to reach $15.7 bn

    Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Singapore: Since 2004, the market for monoclonal antibodies (mAbs) in rheumatoid arthritis (RA) has experienced tremendous growth, and it is on the verge of entering a historically unpreced...Read more

  • Amgen & Astellas form JV, will co-develop biologics

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

    Singapore: US-based Amgen and Japanese firm Astellas Pharma have entered into a strategic alliance to co-develop and co-commercialize five Amgen pipeline medicines in Japan. The five medic...Read more

  • Diagnostic kit to assess kidney cancer treatment result

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2014

    Singapore: Researchers at Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed a molecular te...Read more

  • Singapore scientists find new pattern in immune cell mechanism

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2014

    Singapore: Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have identified relationship between two cells which serve human body's natural defence mechanisms against disea...Read more

  • miRNA tools market clocked $110 mn in 2012: Frost

    Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and therapeutic potential, has led to the the global miRNA tools and service...Read more

  • China to offer personalized chemotherapy

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2014

    Singapore: China-based Fosun diagnostics and Saladax Biomedical announced the launch of MyCare assay tests for chemotherapy in China. Saladax Biomedical in partnership with Fosun diagnostic...Read more

  • Green Cross to set up cell therapy plant in China

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2015

    Singapore: Green Cross, South Korean biopharmaceutical company, is expanding its manufacturing base by building a new cell therapy manufacturing facility in Guizhou province of China. The n...Read more

  • Takeda partners with Monash University

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2014

    Singapore: The Japanese pharma major Takeda, recently announced that the company has entered into a strategic partnership with Monash Institute of Pharmaceutical Sciences (MIPS) at Monash U...Read more

  • Taiwan researchers find link between obesity and arterial stiffness

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Dec, 2014

    Singapore: According to a recent research at Taiwan based National Cheng Kung University (NCKU), obesity leads to a reduction in the protein lysyl oxidase (LOX) which accelerates aortic agi...Read more

  • DNA repair drug could treat leukaemia: Singapore

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Aug, 2014

    Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designed for killing a limited type of cancer cells with DNA repair defects ...Read more

  • Singapore's AYOXXA closes $12.2 mn funding round

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2014

    Singapore: Singapore and Germany based biotech company, AYOXXA Biosystems, has completed $12.28 million (€9 million) Series B financing round. AYOXXA Biosystems has developed a propr...Read more

  • Biosimilars to take over biologic market by 2019'

    Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2014

    Singapore: The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected compound annual growth rate (CAG...Read more

  • Japanese nod for Janssen psoriatic arthritis drug

    Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Sep, 2013

    Singapore: European Commission has approved Janssen-Cilag International's Stelara (ustekinumab), as a stand-alone drug or in combination with methotrexate, for the treatment of active psori...Read more

  • Chinese govt delay hinders GMP plant set up

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced that the construction of a new production facility at its Guizhou ...Read more

  • German firm gets EU patent for dsRNA modification

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Singapore: German company, Riboxx Pharmaceuticals, received patent from European Patent Office (EPO) on a novel process for the manufacturing of double-stranded RNA (dsRNA) bearing chemical...Read more

  • 3SBio acquires patents for kidney failure drug

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2013

    Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acquired patents for DJ5, a novel non-TZD PPARgamma agonist with potentia...Read more

  • Asia leverages on the biologics opportunity

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

    Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of active pharmaceutical ingredients, but they still need to build their s...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls